Assessment of pulmonary toxicity in mice to evaluate human health risks from indoor airborne microorganisms

Mi-Kyung Song1, Jun Woo Kim1, Dong Im Kim1

  • 1Center for Respiratory Research, Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, Jeongeup 56212, Republic of Korea.

PubMed

Insights

Indoor airborne microorganisms, like fungi, can cause lung inflammation and injury in humans. This study found potentially harmful exposure levels, highlighting the need for better indoor air quality standards.

Area of Science:

  • Environmental Health
  • Microbiology
  • Toxicology

Background:

  • Indoor air quality is crucial for human health, with airborne microorganisms posing a significant risk.
  • While indoor chemical toxicity is known, the pulmonary effects of microorganisms are less understood.
  • This research addresses the impact of resident airborne microbes on respiratory health.

Purpose of the Study:

  • To assess the pulmonary effects of dominant airborne microorganisms found indoors in South Korea.
  • To establish a human equivalent exposure threshold for adverse lung responses.
  • To provide toxicological data for improved indoor air microorganism management standards.

Main Methods:

  • Isolation of bacteria and fungi from 240-1029 indoor air sites across South Korea.
  • Intratracheal instillation of selected microbial strains into C57BL/6 mice over four weeks.
  • Analysis of broncho-alveolar lavage fluid for inflammatory markers and lung histology.

Main Results:

  • All exposure groups exhibited increased inflammatory cells and cytokines in broncho-alveolar lavage fluid.
  • Histological examination revealed lung injury, including inflammatory cell infiltration and mucous cell hyperplasia.
  • Calculated benchmark dose (BMD10) and human equivalent exposure thresholds indicated potential harm from indoor fungi.

Conclusions:

  • Indoor airborne microorganisms, particularly fungi, can induce toxic responses and lung injury in humans.
  • Current indoor exposure levels may pose a risk for disease-associated inflammatory lung conditions.
  • The findings support the development of stricter standards for managing indoor microbial contaminants.